C12Y 114/11032
Codeine 3-o-demethylase
Official title: Codeine 3-O-demethylase (1.14.11.32)
C12Y114/11032 (Codeine 3-o-demethylase) appears on 2 US grants and 5 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 5
- Assignees
- 4
- Inventors
- 14
- Latest grant
- 23 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 2 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
By publication year.
Recent patents
- Process11 Sep 2025US 2025/0283129 A1Sun Pharmaceutical Industries (Australia) Pty Ltd
- Microbial cell with improved in vivo conversion of thebaine/oripavine9 Dec 2021US 2021/0380995 A1River Stone Biotech, LLC
- High thebaine poppy and methods of producing the same12 Aug 2021US 2021/0246460 A1Api Labs Inc.
- High thebaine poppy and methods of producing the same6 Jun 2019US 2019/0169625 A1Api Labs Inc.
- Papaver bracteatum with modified alkaloid content9 Jan 2014US 2014/0013465 A1TPI Enterprises Ltd.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.